Axon Enterprise
AXON Nasdaq Aerospace & Defense Financials FY2016βFY2025
Axon Enterprise's revenue rose 33.5% to $2.8 billion in fiscal 2025. Its operating margin was β2.2%, down from 2.8% a year earlier. Free cash flow was $75 million, down 77.2%. The diluted share count rose 4.8%.
About these figures. Axon had no borrowings before it issued convertible notes in December 2022 (its credit line was undrawn), so debt counts as zero in earlier years. In 2024 Axon's convertible notes were due within a year and its amended 10-K moved them to a current line, which is counted as debt.
What Axon Enterprise does
Axon sells technology to police, other public safety agencies and some private customers. It describes itself as a company that sells both hardware and software that work together. Its products include TASER stun devices, body cameras, in-car and fixed cameras, drones, and cloud software for storing and sharing video evidence, writing reports and running real-time operations. Many of its software tools use artificial intelligence.
It reports two segments. Software and Services sells cloud subscriptions, such as Axon Evidence, Axon Records and the Draft One report-writing tool, along with professional services and some on-premise software licenses. Connected Devices sells TASER devices, body and other cameras, drone and counter-drone products, accessories and extended warranties. Its revenue comes from hardware sales, multi-year software subscriptions, professional services and extended warranties.
Axon is based in Scottsdale, Arizona, and is expanding in Europe, Asia and the Americas. Its largest customers are law enforcement agencies, so its sales depend on their budgets and their acceptance of its products.
- Legal name
- AXON ENTERPRISE, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001628280-26-011360
0001069183
Revenue and margins
Axon Enterprise had $2.8B of revenue in fiscal 2025, up 33.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 18.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $75.1M in fiscal 2025, 2.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Axon Enterprise returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 4.9%.
Value Axon Enterprise yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$104M and divides by 82.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 174.4x Β· peers 32.0x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Axon Enterprise can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $371M | $936M | $1.2B | $788M | $1.7B |
| Debt incl. finance leases | $0.0M | $674M | $677M | $680M | $1.8B |
| Net debt / EBITDA | β | β2.3x | β3.2x | β1.0x | 4.9x |
| Debt / equity | 0.0x | 0.5x | 0.4x | 0.3x | 0.6x |
| Interest coverage | β | β | 22.4x | 8.3x | β0.7x |
| Current ratio | 2.7x | 3.0x | 3.1x | 1.4x | 2.5x |
| Quick ratio | 2.4x | 2.7x | 2.8x | 1.2x | 2.3x |
| Total assets | $1.7B | $2.9B | $3.4B | $4.5B | $7.0B |
| Total liabilities | $640M | $1.6B | $1.8B | $2.1B | $3.8B |
| Shareholders' equity | $1.1B | $1.3B | $1.6B | $2.3B | $3.2B |
| Net debt (β = net cash) | β$371M | β$262M | β$565M | β$108M | $104M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$55.9M
6 insiders
Of sales under plans
87%
$48.8M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Isaiah FieldsChief Legal Officer | Sold plan | 1,017 | $480.45 | $0.5M | Form 4 |
| Sep 8, 2026 | Patrick W SmithChief Executive Officer, Director | Sold plan | 10,000 | $508.99 | $5.1M | Form 4 |
| Aug 31, 2026 | Joshua IsnerPresident | Sold plan | 16,775 | $574.43 | $9.6M | Form 4 |
| Aug 21, 2026 | Jeffrey C KuninsCpo & CTO | Sold plan | 9,605 | $626.70 | $6.0M | Form 4 |
| Aug 7, 2026 | Patrick W SmithChief Executive Officer, Director | Sold plan | 9,930 | $548.77 | $5.4M | Form 4 |
| Aug 7, 2026 | Patrick W SmithChief Executive Officer, Director | Sold plan | 70 | $566.62 | $0.0M | Form 4 |
| Jul 7, 2026 | Patrick W SmithChief Executive Officer, Director | Sold plan | 10,000 | $643.79 | $6.4M | Form 4 |
| Jun 29, 2026 | Patrick W SmithChief Executive Officer, Director | Sold plan | 10,000 | $500.00 | $5.0M | Form 4 |
| Jun 5, 2026 | Joshua IsnerPresident | Sold | 13,000 | $488.45 | $6.3M | Form 4 |
| Jun 4, 2026 | Cameron BrooksChief Revenue Officer | Sold plan | 1,242 | $500.00 | $0.6M | Form 4 |
| Jun 4, 2026 | Elizabeth Reid CoughlinChief Human Officer | Sold | 1,554 | $485.00 | $0.8M | Form 4 |
| Jun 4, 2026 | Patrick W SmithChief Executive Officer, Director | Sold plan | 20,000 | $500.00 | $10.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 6 / 9 | 6 / 9 |
| Accruals ratio | β0.4% | β0.8% | β1.5% |
| Altman Z'' | 4.81 | 2.73 | 3.38 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Axon Enterprise AXON | $34.7B | 33.5% | β2.2% | 2.7% | β2.2% | 174.4x | 6 | |
| BWX Technologies BWXT | $11.7B | 18.3% | 12.7% | 9.2% | 13.9% | 33.0x | 7 | Compare β |
| Curtiss-Wright CW | $17.2B | 12.1% | 18.1% | 15.8% | 15.9% | 32.0x | 8 | Compare β |
| Moog MOG-A | $11.0B | 7.0% | 11.7% | 3.3% | 11.7% | 29.0x | 7 | Compare β |
| AeroVironment AVAV | $6.1B | 140.9% | β15.7% | β7.1% | β9.1% | β | 3 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $268M | $344M | $420M | $531M | $681M | $863M | $1.2B | $1.6B | $2.1B | $2.8B |
| Gross profit | $171M | $207M | $259M | $307M | $416M | $541M | $726M | $956M | $1.2B | $1.7B |
| Research and development | $30.6M | $55.4M | $76.9M | $101M | $123M | $194M | $234M | $304M | $442M | $684M |
| Operating income | $31.9M | $13.0M | $24.8M | β$6.4M | β$14.1M | β$168M | $93.0M | $157M | $58.5M | β$62.1M |
| Interest expense | β | β | β | β | β | β | $0.0M | $7.0M | $7.1M | $94.2M |
| Pretax income | $31.5M | $15.8M | $28.1M | $2.1M | β$6.3M | β$141M | $196M | $157M | $382M | $19.0M |
| Income tax | $14.2M | $10.6M | β$1.1M | $1.2M | β$4.6M | β$81.4M | $49.3M | β$18.7M | $4.5M | β$106M |
| Net income | $17.3M | $5.2M | $29.2M | $0.9M | β$1.7M | β$60.0M | $147M | $176M | $377M | $125M |
| Diluted EPS | $0.32 | $0.10 | $0.50 | $0.01 | β$0.03 | β$0.91 | $2.03 | $2.33 | $4.80 | $1.51 |
| Diluted shares | 0.05B | 0.05B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B | 0.08B | 0.08B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | $21.1M | $18.5M | $63.9M | $65.7M | $38.5M | $125M | $235M | $189M | $408M | $211M |
| Capital expenditure | $5.0M | $10.4M | $11.1M | $15.9M | $72.6M | $49.9M | $55.8M | $59.6M | $78.8M | $136M |
| Free cash flow | $16.2M | $8.1M | $52.7M | $49.7M | β$34.2M | $74.6M | $180M | $130M | $330M | $75.1M |
| Depreciation and amortization | $3.7M | $8.0M | $10.6M | $11.4M | $12.5M | $18.7M | $23.1M | $19.3M | $48.4M | $83.2M |
| Stock-based compensation | $9.4M | $15.6M | $21.9M | $78.5M | $134M | $303M | $106M | $131M | $383M | $634M |
| Acquisitions | $3.5M | $10.6M | $5.0M | $0.0M | $0.0M | $22.4M | $2.1M | $21.1M | $622M | $647M |
| Share buybacks | $33.7M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $33.8M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $89.1M | $82.0M | $350M | $351M | $562M | $371M | $936M | $1.2B | $788M | $1.7B |
| Total debt | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $674M | $677M | $680M | $1.8B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $177M | $205M | $558M | $610M | $982M | $1.1B | $1.8B | $2.4B | $2.3B | $3.7B |
| Current liabilities | $78.0M | $108M | $166M | $196M | $256M | $419M | $603M | $762M | $1.7B | $1.5B |
| Inventory | $34.8M | $45.5M | $33.8M | $38.8M | $90.0M | $109M | $203M | $270M | $265M | $342M |
| Property and equipment, net | $24.0M | $31.2M | $37.9M | $43.8M | $106M | $139M | $170M | $201M | $247M | $331M |
| Total assets | $278M | $338M | $720M | $846M | $1.4B | $1.7B | $2.9B | $3.4B | $4.5B | $7.0B |
| Total liabilities | $127M | $171M | $252M | $302M | $405M | $640M | $1.6B | $1.8B | $2.1B | $3.8B |
| Shareholders' equity | $151M | $167M | $467M | $544M | $976M | $1.1B | $1.3B | $1.6B | $2.3B | $3.2B |
| Margins | ||||||||||
| Gross margin | 63.6% | 60.2% | 61.6% | 57.9% | 61.1% | 62.7% | 61.2% | 61.2% | 59.6% | 59.7% |
| Operating margin | 11.9% | 3.8% | 5.9% | β1.2% | β2.1% | β19.5% | 7.8% | 10.1% | 2.8% | β2.2% |
| EBITDA margin | 13.2% | 6.1% | 8.4% | 0.9% | β0.3% | β17.3% | 9.8% | 11.3% | 5.1% | 0.8% |
| Net margin | 6.5% | 1.5% | 7.0% | 0.2% | β0.3% | β7.0% | 12.4% | 11.3% | 18.1% | 4.5% |
| FCF margin | 6.0% | 2.3% | 12.6% | 9.4% | β5.0% | 8.6% | 15.1% | 8.3% | 15.8% | 2.7% |
| Returns | ||||||||||
| Return on capital | 32.1% | 8.8% | 24.4% | β2.1% | β3.7% | β24.3% | 8.3% | 15.2% | 3.5% | β2.2% |
| Return on capital employed | 16.3% | 6.1% | 6.3% | β1.1% | β1.6% | β14.0% | 5.3% | 6.4% | 2.2% | β1.5% |
| Return on equity | 11.2% | 3.3% | 9.2% | 0.2% | β0.2% | β5.9% | 12.7% | 12.2% | 19.1% | 4.5% |
| Return on assets | 6.8% | 1.7% | 5.5% | 0.1% | β0.2% | β3.9% | 6.5% | 5.6% | 9.6% | 2.2% |
| Growth | ||||||||||
| Revenue growth | 35.6% | 28.2% | 22.2% | 26.4% | 28.3% | 26.8% | 37.5% | 31.5% | 33.4% | 33.5% |
| Net income growth | β13.2% | β69.9% | 460.9% | β97.0% | β295.5% | β | β | 19.6% | 114.5% | β66.9% |
| EPS growth | β11.1% | β68.8% | 400.0% | β98.0% | β400.0% | β | β | 14.8% | 106.0% | β68.5% |
| FCF growth | β60.0% | β50.2% | 554.9% | β5.7% | β168.7% | β | 140.7% | β27.8% | 154.2% | β77.2% |
| Share count change | β2.0% | 0.7% | 7.5% | 3.6% | 2.9% | 7.1% | 9.6% | 4.0% | 4.1% | 4.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | β2.5x | β3.9x | β9.9x | β70.6x | β | β | β2.3x | β3.2x | β1.0x | 4.9x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.5x | 0.4x | 0.3x | 0.6x |
| Interest coverage | β | β | β | β | β | β | β | 22.4x | 8.3x | β0.7x |
| Current ratio | 2.3x | 1.9x | 3.4x | 3.1x | 3.8x | 2.7x | 3.0x | 3.1x | 1.4x | 2.5x |
| Quick ratio | 1.8x | 1.5x | 3.2x | 2.9x | 3.5x | 2.4x | 2.7x | 2.8x | 1.2x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.9% | 3.0% | 2.7% | 3.0% | 10.7% | 5.8% | 4.7% | 3.8% | 3.8% | 4.9% |
| Stock comp / revenue | 3.5% | 4.5% | 5.2% | 14.8% | 19.6% | 35.1% | 8.9% | 8.4% | 18.4% | 22.8% |
| Payouts / FCF | 208.6% | 0.0% | 0.0% | 0.0% | β | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 4.0 | 7.0 | 3.0 | 5.0 | 3.0 | 6.0 | 6.0 | 6.0 | 6.0 |
| Altman Z'' | 5.7 | 4.4 | 6.5 | 5.7 | 6.3 | 4.0 | 4.1 | 4.8 | 2.7 | 3.4 |
| Accruals ratio | β1.5% | β4.3% | β6.6% | β8.3% | β3.6% | β12.0% | β3.9% | β0.4% | β0.8% | β1.5% |
Source: SEC EDGAR XBRL filings (CIK 0001069183). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.